- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
Progeria is a rare genetic disorder that causes accelerated aging in children. It is a part of the larger category of endocrine and metabolic disorders drugs. These drugs are used to treat a variety of conditions, including diabetes, obesity, and thyroid disorders. Progeria drugs are designed to slow the progression of the disease and improve the quality of life for those affected.
The Progeria drug market is relatively small, but it is growing as more research is conducted and new treatments are developed. Companies in the market are focused on developing treatments that can slow the progression of the disease and improve the quality of life for those affected. Some of the companies in the market include Genentech, Novartis, and Pfizer. Show Less Read more